Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on September 18, 2008

Arteriosclerosis, Thrombosis, and Vascular Biology. 2008
Published online before print September 18, 2008, doi: 10.1161/ATVBAHA.108.175620
A more recent version of this article appeared on December 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
28/12/2303    most recent
ATVBAHA.108.175620v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stroes, E. S.
Right arrow Articles by Kuivenhoven, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stroes, E. S.
Right arrow Articles by Kuivenhoven, J. A.

Submitted on June 25, 2008
Accepted on September 8, 2008

Intramuscular Administration of AAV1-Lipoprotein LipaseS447X Lowers Triglycerides in Lipoprotein Lipase–Deficient Patients

Erik S. Stroes ; Melchior C. Nierman ; Janneke J. Meulenberg ; Remco Franssen ; Jaap Twisk ; C. Pieter Henny ; Mario M. Maas ; Aeilko H. Zwinderman ; Colin Ross ; Eleonora Aronica ; Katherine A. High ; Marcel M. Levi ; Michael R. Hayden ; John J. Kastelein *; and Jan Albert Kuivenhoven

From Vascular Medicine (E.S.S., M.C.N., R.F., J.J.K., J.A.K.), the Departments of Anaesthesiology (C.P.H.), Radiology (M.M.M.), Biostatistics (A.H.Z.), and (Neuro)pathology (E.A.), and Internal Medicine (M.M.L.), AMC, the Netherlands; Amsterdam Molecular Therapeutics (J.J.M., J.T.), the Netherlands; the Centre for Molecular Medicine and Therapeutics (C.R., M.R.H.), University of British Columbia, Vancouver, Canada; and Children's Hospital (K.A.H.), University of Pennsylvania School of Medicine, Philadelphia.

* To whom correspondence should be addressed. E-mail: j.s.jansen{at}amc.uva.nl.




This article has been cited by other articles:


Home page
 BloodHome page
T. VandenDriessche
Muscling through AAV immunity
Blood, September 3, 2009; 114(10): 2009 - 2010.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
F. Mingozzi, J. J. Meulenberg, D. J. Hui, E. Basner-Tschakarjan, N. C. Hasbrouck, S. A. Edmonson, N. A. Hutnick, M. R. Betts, J. J. Kastelein, E. S. Stroes, et al.
AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells
Blood, September 3, 2009; 114(10): 2077 - 2086.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
S. Cecchini, A. Negrete, T. Virag, B. S. Graham, J. I. Cohen, and R. M. Kotin
Evidence of Prior Exposure to Human Bocavirus as Determined by a Retrospective Serological Study of 404 Serum Samples from Adults in the United States
Clin. Vaccine Immunol., May 1, 2009; 16(5): 597 - 604.
[Abstract] [Full Text] [PDF]


ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.